A peptide is only the molecule you wanted if every stereocenter points the right way. Nature builds proteins almost entirely from left-handed (L) amino acids, and a synthesizer is supposed to do the same — but the chemistry of stitching residues together can quietly flip one of those centers to its mirror image. When that happens, you no longer have your target sequence. You have an impurity that looks almost identical on paper. This article is educational and covers material relevant to peptides sold for research use only, and it explains the two chemistry problems most responsible for that outcome: racemization during coupling, and aspartimide formation at aspartic acid and asparagine.
If you are researching a synthetic peptide, these two side reactions explain a large share of what ends up on a certificate of analysis. They tell you why certain sequences are harder to make cleanly than others, and why analytical characterization matters so much for research-grade material. We will define the terms, walk through the two coupling-step mechanisms, look at the aspartimide special case, name the residues that break first, and finish with the toolkit chemists use to keep synthesis on the rails.
What racemization and epimerization actually mean
Every amino acid except glycine has a central carbon — the alpha-carbon — bonded to four different groups. That asymmetry makes the molecule chiral: it can exist in two non-superimposable mirror-image forms, labeled L and D. Living systems overwhelmingly use the L form, and the arrangement of D- and L-amino acid chirality is a large part of what gives a peptide its defined shape and behavior.
Racemization is the loss of that single-handedness: a sample that started as pure L drifts toward a mixture of L and D. Epimerization is the narrower term for inverting one stereocenter in a molecule that contains several — which is exactly what happens when a single residue in an otherwise all-L chain flips. In peptide chemistry the two words are often used interchangeably, because inverting one alpha-carbon produces a diastereomer, an epimer, that is functionally a racemized residue at that position.
Why does one flipped center matter? It is not a cosmetic change. The epimer is a genuinely different molecule with a different three-dimensional structure, different chromatographic behavior, and, in a research setting, potentially different activity in whatever assay it is being studied. A peptide that is 95% correct and 5% epimerized is a 95%-pure preparation — and that impurity has to be measured and reported.
Two roads to a scrambled stereocenter: enolization versus oxazolone
During synthesis, the vulnerable moment is coupling — the step where an incoming, carboxyl-activated amino acid is joined to the growing chain. Two well-characterized chemical routes can scramble the alpha-carbon at exactly that point.
Direct base-driven enolization
The alpha-carbon carries a single hydrogen, the alpha-proton. Because it sits next to a carbonyl, that proton is mildly acidic, and a base can pull it off. Once it is gone, the carbon flattens into a planar enolate: the four groups that used to sit in a fixed three-dimensional arrangement now lie in a plane. When a proton adds back, it can arrive from either face with roughly equal odds — and half the time it rebuilds the D configuration. This base-mediated enolization pathway is why excess base and long exposure times are risk factors.
Oxazolone formation
The second route is usually the bigger culprit during coupling. When the carboxyl group is strongly activated, the backbone carbonyl oxygen can loop back and close a five-membered ring called a 5(4H)-oxazolone. That ring loses its alpha-proton even more readily than the open-chain form, and once it does, re-attack scrambles the center before the residue is ever incorporated. Reviews of the mechanism describe the oxazolone pathway as the predominant source of racemization in most standard couplings.
How the damage is measured
You cannot fix what you cannot see, and the workhorse for seeing epimers is reversed-phase HPLC. Because the inverted stereocenter subtly changes how a peptide interacts with the column, a correctly made peptide and its epimer often split into two peaks that can be integrated. Classic work using RP-HPLC separation of protected epimeric peptides showed that bulky residues at the coupling site racemize heavily in a polar solvent like DMF, that the counterion on an amino-acid salt changes the outcome, and that solvent choice between DMF and dichloromethane measurably shifts the numbers.